DA
DNLI icon

Duality Advisers’s Denali Therapeutics DNLI Stock Holding History

Duality Advisers’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-19,728
Closed -$605K – 628
2022
Q3 		$605K Buy
+19,728
New +$641K 0.07% 389
2022
Q2 		– Sell
-34,200
Closed -$1.1M – 655
2022
Q1 		$1.1M Buy
+34,200
New +$1.18M 0.12% 300
2021
Q4 		– Sell
-23,045
Closed -$1.16M – 537
2021
Q3 		$1.16M Buy
+23,045
New +$1.3M 0.09% 323
2021
Q2 		– Sell
-19,642
Closed -$1.12M – 581
2021
Q1 		$1.12M Buy
+19,642
New +$1.31M 0.1% 328

Other funds holding DNLI

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return